Rajesh Chopra - Concepedia

Author

Rajesh Chopra

Also Known As

Chopra, Rajesh, Dr. R. K. Chopra, R Chopra, R K CHOPRA, R K Chopra, R. Chopra, R. K. Chopra, R.K. Chopra, RAJESH K. CHOPRA, Rajesh Chopra

275

Publications

15.3K

Citations

H-Index

156

Concepts

All Affiliations

University College London The Christie Hospital Bristol-Myers Squibb (Switzerland)Institute of Cancer Research National Institute on Aging

About

Rajesh Chopra is an author at University College London specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	43	5.3K
2	Health Sciences	10	10	1.9K
3	Engineering	3	3	180
4	Allergy	2	2	320
5	Public Health	1	1	92

Rajesh Chopra

103

Publications

13.2K

Citations

H-Index

Page 1

	Year	Citations
Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial David C. Linch, A. H. Goldstone, Annabel McMillan, The Lancet TransplantationMarrow TransplantationStem Cell TransplantationHematologyCell Replacement Therapy	1993	1K
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study Adele K. Fielding, Susan Richards, Rajesh Chopra, Blood	2006	827
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS Jan Krönke, Emma C. Fink, Paul W. Hollenbach, Nature MedicineCell DeathPharmacologyCell BiologyCell Signaling	2015	816
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide Antonia Lopez‐Girona, Derek Mendy, Takumi Ito, Leukemia	2012	783
Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate <scp>T</scp> cells by inducing degradation of <scp>T</scp> cell repressors <scp>I</scp> karos and <scp>A</scp> iolos via modulation of the <scp>E</scp> 3 ubiquitin ligase complex <scp>CRL</scp> 4 <scp> <sup>CRBN</sup> </scp> Anita K. Gandhi, Jian Kang, Courtney G. Havens, British Journal of Haematology	2013	611
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation Panagiotis Kottaridis, Donald Milligan, Rajesh Chopra, Blood	2000	502
Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis Rajasekhar N.V.S. Suragani, Samuel M. Cadena, Sharon M Cawley, Nature Medicine AnemiaTrap Ace-536 CorrectsLate-stage ErythropoiesisIron MetabolismImmunology	2014	421
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen Ronjon Chakraverty, Karl S. Peggs, Rajesh Chopra, Blood	2002	344
The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight- year study of 155 patients Rajesh Chopra, AK McMillan, DC Linch, Blood	1993	319
Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity Peter Schäfer, Anastasia Parton, Lori Capone, Cellular Signalling	2014	302

Page 1